Family-based association studies between 5-HT5A receptor gene and schizophrenia

Journal of Psychiatric Research

Volumn 38, Issue 4, 2004, Pages 371-376

  Dubertret, C ^a,b   Hanoun, N ^b   Ades J ^a   Hamon, M ^b   Gorwood, P ^a,b  

^a HÔPITAL LOUIS MOURIER   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

5 HT5A gene; Age at onset; Haplotype; Q TDT; Schizophrenia; TDT

Indexed keywords

PROLINE; SERINE; SEROTONIN 5A RECEPTOR;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CATATONIC SCHIZOPHRENIA; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DNA POLYMORPHISM; EXON; FAMILY HISTORY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CORRELATION; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NEGATIVE SYNDROME; ONSET AGE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; RECEPTOR GENE;

ADULT; AGE OF ONSET; AGED; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SCHIZOPHRENIA;

EID: 2942596328     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2004.01.002     Document Type: Article

References (34)

1. Abecasis G.R., Cardon L.R., Cookson W.O. A general test of association for quantitative traits in nuclear families. American Journal of Human Genetics. 66:2000;279-292
2. Aghajanian G.K., Marek G.J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Research: Brain Research Reviews. 31:2000;302-312
3. Andreasen N.C. Scale for assessment of negative symptoms (SANS). 1981;University of Iowa, Iowa city
4. Andreasen N.C. Scale for assessment of positive symptoms (SAPS). 1983;University of Iowa, Iowa city
5. Andreasen N.C., Olsen S. Negative versus positive schizophrenia: a critical appraisal. Archieves of General Psychiatry. 39:1982;789-794
6. Birkett J.T., Arranz M.J., Munro J., Osbourn S., Kerwin R.W., Collier D.A. Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response. Neuroreport. 11:2000;2017-2020
7. 5A serotonin receptor is expressed predominantly by astrocytes in which it inhibits cAMP accumulation: a mechanism for neuronal suppression of reactive astrocytes. Glia. 17:1996;317-326
8. Daly M.J., Rioux J.D., Schaffner S.F., Hudson T.J., Lander E.S. High-resolution haplotype structure in the human genome. Nature Genetics. 29:2001;229-232
9. DeLisi L.E., Golden L.R., Gershon E.S. Studies of biological factors associated with inheritance of schizophrenia: a selective review. Journal of Psychiatry Research. 21:1987;507-513
10. Drysdale C.M., McGraw D.W., Stack C.B., Stephens J.C., Judson R.S., Nandabalan K., et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proceedings of the National Academic Sciences of USA. 97:2000;10483-10488
11. Dubertret C., Gorwood P., Gouya L., Deybach J.C., Adès J. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. Schizophrenia Research. 49:2001;203-212
12. Falk C.T., Rubinstein P. Haplotype relative risk: an easy reliable way to construct a proper control sample for risk calculation. Annals of Human Genetics. 51:1987;227-233
13. Francken B.J., Josson K., Lijnen P., Jurzak M., Luyten W.H., Leysen J.E. Human 5-hydroxytryptamine(5A) receptors activate coexpressed G (i) and G (o) proteins in Spodoptera frugiperda 9 cells. Molecular Pharmacology. 57:2000;1034-1044
14. Gorwood P. Genetic association studies in behavioral neuroscience. Cruzio W., Gerlai R. Molecular genetic techniques for behavioural neuroscience. 1999;113-121 Elsevier, Amsterdam
15. Grailhe R., Waeber C., Dulawa S.C., Hornung J.P., Zhuang X., Brunner D., et al. Increased exploratory activity and altered response to LSD in mice lacking the 5-HT(5A): receptor. Neuron. 22:1999;581-591
16. Iwata N., Ozaki N., Inada T., Goldman D. Association of a 5-HT(5A) receptor polymorphism, C43T, to schizophrenia. Molecular Psychiatry. 6:2001;217-219
17. Iwata N., Virkkunen M., Linnoila M., Goldman D. Identification of a naturally occurring 43C-Ser15 substitution in the serotonin5A receptor gene in alcoholics and healthy volunteers. Brain Research: Molecular Brain Research. 58:1998;217-220
18. Johnson G.C., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., et al. Haplotype tagging for the identification of common disease genes. Nature Genetics. 29:2001;233-237
19. Kidd K.K., Morar B., Castiglione C.M., Zhao H., Pakstis A.J., Speed W.C., et al. A global survey of haplotype frequencies and linkage disequilibrium at the DRD2 locus. Human Genetics. 103:1998;211-227
20. Martin E.R., Lai E.H., Gilbert J.R., Rogala A.R., Afshari A.J., Riley J., et al. SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. American Journal of Human Genetics. 67:2000;383-394
21. Meltzer H.Y. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology. 21:1999;106S-115S
22. Nurnberger JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J, Severe JB, Malaspina D, Reich T and collaborators from the NIMH. Genetics Initiative Diagnostic Interview for Genetic Studies Rationale, Unique Features, and Training. Archieves of General Psychiatry 1994;51:849-59
23. Otts J. Statistical properties of the haplotype relative risk. Genetic Epidemiology. 6:1989;127-130
24. 5A serotonin receptor mRNA in the human brain. Brain Research: Molecular Brain Research. 56:1998;1-8
25. Prasad S., Semwal P., Deshpande S., Bhatia T., Nimgaonkar V.L., Thelma B.K. Molecular genetics of schizophrenia: past, present and future. Journal of Biosciences. 27:2002;35-52
26. 5A serotonin receptor. FEBS Lett. 355:1994;242-246
27. Schanen N.C., Scherer S.W., Tsui L.C., Francke U. Assignment of the 5-hydroxytryptamine (serotonin) receptor 5A gene (HTR5A) to human chromosome band 7q36.1. Cytogenetics and Cell Genetics. 72:1996;187-188
28. Schiefermeier M., Kollegger H., Madl C., Polli C., Oder W., Kuhn H., et al. The impact of apolipoprotein E genotypes on age at onset of symptoms and phenotypic expression in Wilson's disease. Brain. 123:2000;585-590
29. ′ untranslated region Biochemical Biophysics Research Communications. 233:1997;6-9
30. Spielman R., Ewens W. The TDT and other family-based tests for linkage disequilibrium and association. American Journal of Human Genetics. 59:1996;983-989
31. Spielman R.S., McInnis R.E., Ewens W.J. Transmission Test for Linkage Disequilibrium: The insulin gene region and insulin-dependent diabetes mellitus (IDDM). American Journal of Human Genetics. 52:1993;506-516
32. Thompson E.A., Deep S., Walker D., Motulsky A.G. Detection of linkage disequilibrium between closely linked markers: RFLPs at the AI-CIII apolipoprotein genes. American Journal of Human Genetics. 42:1988;113-124
33. Verdoux H., Geddes J.R., Takei N., Lawrie S.M., Bovet P., Eagles J.M., et al. Obstetric complications and age at onset in schizophrenia: an international collaborative meta-analysis of individual patient data. American Journal of Psychiatry. 154:1997;1220-1227
34. Zhao H., Zhang S., Merikangas K.R., Trixler M., Wildenauer D.B., Sun F., Kidd K.K. Transmission/disequilibrium tests using multiple tightly linked markers. American Journal of Human Genetics. 67:2000;936-946